Figure 8 displays a strong correlation between YHJD and SIGLEC1 in clinical and animal CRC samples, indicating that YHJD inhibits SIGLEC1 expression and restricts tumor growth and metastasis. This evidence concerns the gene SIGLEC1 and neoplasm.